de Oliveira L, Lopes D, Gomes J, da Silveira R, Nozaki D, Santos L
J Clin Med. 2024; 13(14).
PMID: 39064078
PMC: 11277332.
DOI: 10.3390/jcm13144038.
Thoenissen P, Heselich A, Burck I, Sader R, Vogl T, Ghanaati S
Front Oncol. 2023; 13:972042.
PMID: 36959788
PMC: 10028140.
DOI: 10.3389/fonc.2023.972042.
Haidari S, Obermeier K, Kraus M, Otto S, Probst F, Liokatis P
Cancers (Basel). 2022; 14(17).
PMID: 36077775
PMC: 9454590.
DOI: 10.3390/cancers14174241.
Redman J, Friedman J, Robbins Y, Sievers C, Yang X, Lassoued W
J Clin Invest. 2022; 132(18).
PMID: 35727629
PMC: 9479764.
DOI: 10.1172/JCI161400.
Thoenissen P, Heselich A, Deeg S, Al-Maawi S, Tanneberger A, Sader R
Front Oncol. 2022; 12:812864.
PMID: 35686113
PMC: 9172998.
DOI: 10.3389/fonc.2022.812864.
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [F]FDG PET/CT and MRI.
Linz C, Brands R, Kertels O, Dierks A, Brumberg J, Gerhard-Hartmann E
Eur J Nucl Med Mol Imaging. 2021; 48(12):3951-3960.
PMID: 34050405
PMC: 8484183.
DOI: 10.1007/s00259-021-05422-z.
Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
Linz C, Brands R, Herterich T, Hartmann S, Muller-Richter U, Kubler A
JAMA Netw Open. 2021; 4(4):e217083.
PMID: 33881529
PMC: 8060833.
DOI: 10.1001/jamanetworkopen.2021.7083.
A prospective clinical trial of the second-look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer.
Nishimura G, Sano D, Arai Y, Hatano T, Takahashi H, Tanabe T
Cancer Med. 2019; 8(17):7197-7206.
PMID: 31595716
PMC: 6885886.
DOI: 10.1002/cam4.2588.
Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery.
Joo Y, Cho J, Koo B, Kwon M, Kwon S, Kwon S
Clin Exp Otorhinolaryngol. 2019; 12(2):107-144.
PMID: 30703871
PMC: 6453784.
DOI: 10.21053/ceo.2018.01816.
The Second-Look Procedure for Transoral Videolaryngoscopic Surgery for T1 and T2 Laryngeal, Oropharyngeal, and Hypopharyngeal Cancer Patients: Protocol for a Nonrandomized Clinical Trial.
Nishimura G, Sano D, Yabuki K, Arai Y, Chiba Y, Tanabe T
JMIR Res Protoc. 2017; 6(12):e235.
PMID: 29208591
PMC: 5736877.
DOI: 10.2196/resprot.8907.
F-FLT and F-FDG PET/CT in Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma: Preliminary Results.
Qi S, Zhongyi Y, Yingjian Z, Chaosu H
Sci Rep. 2017; 7:40552.
PMID: 28091565
PMC: 5238364.
DOI: 10.1038/srep40552.
CT Accuracy of Extrinsic Tongue Muscle Invasion in Oral Cavity Cancer.
Junn J, Baugnon K, Lacayo E, Hudgins P, Patel M, Magliocca K
AJNR Am J Neuroradiol. 2017; 38(2):364-370.
PMID: 28059707
PMC: 7963804.
DOI: 10.3174/ajnr.A4993.
(18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications.
Manca G, Vanzi E, Rubello D, Giammarile F, Grassetto G, Wong K
Eur J Nucl Med Mol Imaging. 2016; 43(7):1360-75.
PMID: 26780912
DOI: 10.1007/s00259-015-3294-0.
Comparison of Dynamic Contrast-Enhanced MRI and PET/CT in the Evaluation of Laryngeal Cancer After Inadequate CT Results.
Citil S, Dogan S, Atilgan H, Menzilcioglu M, Sahin T, Abdulrezzak U
Pol J Radiol. 2015; 80:428-32.
PMID: 26445625
PMC: 4577024.
DOI: 10.12659/PJR.895041.
Computed tomography versus magnetic resonance imaging for diagnosing cervical lymph node metastasis of head and neck cancer: a systematic review and meta-analysis.
Sun J, Li B, Li C, Li Y, Su F, Gao Q
Onco Targets Ther. 2015; 8:1291-313.
PMID: 26089682
PMC: 4467645.
DOI: 10.2147/OTT.S73924.
Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India.
Nair S, Mohan S, Nilakantan A, Gupta A, Malik A, Gupta A
World J Nucl Med. 2015; 14(1):19-24.
PMID: 25709540
PMC: 4337002.
DOI: 10.4103/1450-1147.150519.
Adding maximum standard uptake value of primary lesion and lymph nodes in 18F-fluorodeoxyglucose PET helps predict distant metastasis in patients with nasopharyngeal carcinoma.
Shi Q, Yang Z, Zhang Y, Hu C
PLoS One. 2014; 9(7):e103153.
PMID: 25068373
PMC: 4113368.
DOI: 10.1371/journal.pone.0103153.
Positron emission tomography and stage migration in head and neck cancer.
VanderWalde N, Salloum R, Liu T, Hornbrook M, OKeeffe Rosetti M, Ritzwoller D
JAMA Otolaryngol Head Neck Surg. 2014; 140(7):654-61.
PMID: 24875939
PMC: 6000724.
DOI: 10.1001/jamaoto.2014.812.
Combined SPECT/CT improves detection of initial bone invasion and determination of resection margins in squamous cell carcinoma of the head and neck compared to conventional imaging modalities.
Kolk A, Schuster T, Chlebowski A, Lange P, Scheidhauer K, Kesting M
Eur J Nucl Med Mol Imaging. 2014; 41(7):1363-74.
PMID: 24573657
DOI: 10.1007/s00259-014-2726-6.
FDG-PET, a Complementary Modality to Computed-Tomography in Radiotherapy Target Volume Delineation for Head and Neck Cancer.
Bar-Ad V, Shi W, Tuluc M, Ohri N, Cognetti D, Curry J
J Nucl Med Radiat Ther. 2013; 3(1).
PMID: 24179702
PMC: 3811146.
DOI: 10.4172/2155-9619.1000124.
